News

TipRanks on MSN4h
Invion Advances Non-Melanoma Skin Cancer Trial with Successful Initial Dosing
An announcement from Invion ( ($AU:IVX) ) is now available. Invion Limited has successfully dosed the first six patients in its Phase I/II trial ...